BioSpace News Archive

A research announcement to leverage the unique microgravity environment of the International Space Station for in-space production applications within the biomedical community is now open.

Piramal Pharma Solutions, a market-leading, patient-centric Contract Development and Manufacturing Organization (CDMO), announced the launch of ADCelerate, a new, branded solution for antibody-drug conjugate drug development that accelerates timelines for developing the initial clinical supply of both drug substance and drug product.

Medline and California-based Hoag Memorial Hospital Presbyterian health system have entered into a multi-year prime vendor partnership valued at $200M.

Vivera is pleased to welcome Dr. Geetha Rao to the Company’s Advisory Board as its Regulatory Advisor.

NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2022 third quarter financial results before the opening of the market on Oct 20, 2022.

HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG) completed its planned milestones for the third quarter of 2022, further advancing its transcriptome-informed approach to drug design and discovery utilizing the company’s proprietary HTG EdgeSeq technology.

SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today provided an update on the status of multiple clinical trials now underway to assess the safety and efficacy of TPOXX to treat monkeypox.

AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer, announced today that, as disclosed on uspto.gov, the United States Patent and Trademark Office (“USPTO”) has allowed U.S. Patent Application No. 17/720,619, titled “Use of Tivozanib to Treat Subjects with Refractory Cancer” (the “Application”).

Invivyd, (Nasdaq: IVVD), formerly Adagio Therapeutics (Nasdaq: ADGI), a clinical-stage biopharmaceutical company on a mission to protect humanity from serious viral respiratory diseases announced today that it will have four poster presentations at ID Week 2022.

10x Genomics announced it will report financial results for the third quarter 2022 after market close on Wednesday, November 2, 2022.